CS logo
small CS logo
Riverchase Dermatology and Cosmetic Surgery

Pembroke Pines, Florida, United States
Dermatologist in Pembroke Pines, Florida
603 N Flamingo Rd #350, Pembroke Pines, FL 33028

About Riverchase Dermatology and Cosmetic Surgery


"DERMATOLOGY, Reimagined. At Riverchase Dermatology and Cosmetic Surgery, delivering the best care simply isn’t enough. We go a step further by giving our patients the best experience. Our friendly staff and attentive providers are passionate about helping the most important person in the room—the patient. It is our mission to continue to grow in order to bring this commitment and dedication to reach as many patients as possible. Whether we are training our staff or sending pre-appointment communications, we keep the patient experience at the forefront and center everything around their experience as a whole. We have developed our practice strategically in several key areas to help advance this mission and vision."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
4
Amgen
1
AnaptysBio, Inc.
1
Janssen Research & Development, LLC
1
Pfizer
1
Total Rows: 5

Clinical Trials at Riverchase Dermatology and Cosmetic Surgery


During the past decade, Riverchase Dermatology and Cosmetic Surgery conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years22222211110000001122Started TrialsCompleted Trails201820192020202120220123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis
2018-02-20
2021-08-16
Completed
440
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
2018-06-27
2022-06-13
Terminated
374
A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in Adults With Palmoplantar Pustulosis
2019-05-20
2021-04-23
Completed
59
A Study to Evaluate the Safety and Efficacy of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa
2019-12-02
2022-01-10
Completed
194
Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)
2020-06-15
2024-09-30
Active, not recruiting
1,000
A Study of Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA)
2020-11-17
2022-09-30
Completed
254
A Study to Investigate Interchangeability of ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
2021-03-24
2023-02-28
Completed
494
Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/or Scalp Psoriasis
2022-07-13
2025-07-10
Recruiting
200

Rows per page:

1–8 of 8

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Riverchase Dermatology and Cosmetic Surgery" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Amgen" with 1 trials sponsored, "AnaptysBio, Inc." with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Riverchase Dermatology and Cosmetic Surgery" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator and "Dermira, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsEli Lilly and Company: 4Eli Lilly and Company: 4Amgen: 1Amgen: 1AnaptysBio, Inc.: 1AnaptysBio, Inc.: 1Janssen Research &Development, LLC: 1Janssen Research &Development, LLC: 1Pfizer: 1Pfizer: 1

Created with Highcharts 11.1.0Top CollaboratorsIncyte Corporation: 2Incyte Corporation: 2Dermira, Inc.: 1Dermira, Inc.: 1

Clinical Trials Conditions at Riverchase Dermatology and Cosmetic Surgery


According to Clinical.Site data, the most researched conditions in "Riverchase Dermatology and Cosmetic Surgery" are "Atopic Dermatitis" (4 trials), "Acne Inversa" (1 trials), "Palmoplantar Pustulosis" (1 trials), "Plaque Psoriasis" (1 trials) and "Psoriasis" (1 trials). Many other conditions were trialed in "Riverchase Dermatology and Cosmetic Surgery" in a lesser frequency.

Clinical Trials Intervention Types at Riverchase Dermatology and Cosmetic Surgery


Most popular intervention types in "Riverchase Dermatology and Cosmetic Surgery" are "Drug" (7 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Baricitinib" (2 trials), "Lebrikizumab" (2 trials), "ABP 654" (1 trials) and "Guselkumab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Riverchase Dermatology and Cosmetic Surgery


The vast majority of trials in "Riverchase Dermatology and Cosmetic Surgery" are 8 trials for "All" genders.

Clinical Trials Status at Riverchase Dermatology and Cosmetic Surgery


Currently, there are NaN active trials in "Riverchase Dermatology and Cosmetic Surgery". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Riverchase Dermatology and Cosmetic Surgery, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Riverchase Dermatology and Cosmetic Surgery, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 6Phase 3: 6Phase 2: 2Phase 2: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 5Completed: 5Active, not recruiting: 1Active, not recruiting: 1Recruiting: 1Recruiting: 1Terminated: 1Terminated: 1